Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7204 record(s)

Req # A-2023-001566

The research/studies used by Health Canada to include warnings for “addiction, hallucinations and suicidal ideation” for pregabalin/Lyrica.

Organization: Health Canada

148 page(s)
October 2024

Req # A-2023-001609

The following correspondence between Health Canada and potential sponsor(s) regarding the generic submission currently under review for LANREOTIDE: Abbreviated New Drug Submission (ANDS) application forms, draft Product Monograph, Screening…

Organization: Health Canada

25 page(s)
October 2024

Req # A-2023-001611

Documents and records containing information regarding the mock-ups of every label to be used in connection with the Semaglutide Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

298 page(s)
October 2024

Req # A-2024-000109

All communication documents related to the company Medmira Inc for the period between November 2023 and April 26th 2024.

Organization: Health Canada

103 page(s)
October 2024

Req # A-2024-000127

Documents and records containing information regarding the mock-ups of every label to be used in connection with the Second Semaglutide Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

36 page(s)
October 2024

Req # A-2024-000201

Any internal communications or communications by/from Cannabis and Controlled Substances Branch to governmental agencies or any draft communications questioning whether a cannabis product with a brand element or brand name or product name containing…

Organization: Health Canada

35 page(s)
October 2024

Req # A-2024-000209

The Standard Operating Procedure on Signal Response Protocol between Health Canada and the Public Health Agency of Canada which includes a Common Core Issues Management Process for COVID-19 Vaccines.

Organization: Health Canada

14 page(s)
October 2024

Req # A-2024-000210

All of the communications, memos, revisions, emails, attachments, briefs, meeting notes that Dr Supriya Sharma made with respect to the Vaccine Reporting Webpage from January 2020 to May 22, 2024.

Organization: Health Canada

51 page(s)
October 2024

Req # A-2024-000458

Seeking drug product testing and/or lot release results conducted by Health Canada or any other external party concerning Comirnaty COVID-19 vaccine and SpikeVax COVID-19 vaccines.

Organization: Health Canada

118 page(s)
October 2024

Req # A-2024-000471

The Imperial Tobacco Canada Ltd. submission in response to the Consultation on the Legislative Review of the Tobacco and Vaping Products Act <https://www.canada.ca/en/health-canada/programs/consultation-legislative-review-tobacco-vaping-products-…

Organization: Health Canada

40 page(s)
October 2024
Date modified: